» Articles » PMID: 29596429

Age-related Collagen Turnover of the Interstitial Matrix and Basement Membrane: Implications of Age- and Sex-dependent Remodeling of the Extracellular Matrix

Overview
Journal PLoS One
Date 2018 Mar 30
PMID 29596429
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The extracellular matrix (ECM) plays a vital role in maintaining normal tissue function. Collagens are major components of the ECM and there is a tight equilibrium between degradation and formation of these proteins ensuring tissue health and homeostasis. As a consequence of tissue turnover, small collagen fragments are released into the circulation, which act as important biomarkers in the study of certain tissue-related remodeling factors in health and disease. The aim of this study was to establish an age-related collagen turnover profile of the main collagens of the interstitial matrix (type I and III collagen) and basement membrane (type IV collagen) in healthy men and women. By using well-characterized competitive ELISA-assays, we assessed specific fragments of degraded (C1M, C3M, C4M) and formed (PINP, Pro-C3, P4NP7S) type I, III and IV collagen in serum from 617 healthy men and women ranging in ages from 22 to 86. Subjects were divided into 5-year age groups according to their sex and age. Groups were compared using Kruskal-Wallis adjusted for Dunn's multiple comparisons test and Mann-Whitney t-test. Age-specific changes in collagen turnover was most profound for type I collagen. PINP levels decreased in men with advancing age, whereas in women, the level decreased in early adulthood followed by an increase around the age of menopause (age 40-60). Sex-specific changes in type I, III and IV collagen turnover was present at the age around menopause (age 40-60) with women having an increased turnover. In summary, collagen turnover is affected by age and sex with the interstitial matrix and the basement membrane being differently regulated. The observed changes needs to be accounted for when measuring ECM related biomarkers in clinical studies.

Citing Articles

Prevalence, risk factors, and adverse outcomes of diastasis of rectus abdominis in men: a cross-sectional study.

Zhu C, Shen Y, Wang L, Gu Y, Yu X, Wu L Hernia. 2024; 29(1):31.

PMID: 39601914 DOI: 10.1007/s10029-024-03225-3.


Ovariectomy drives increase of an ECM transcription signature in the posterior eye and retina.

Wong C, Sanchez-Rodriguez G, Ethier C, Wood L, Feola A Vision Res. 2024; 225:108507.

PMID: 39476526 PMC: 11771480. DOI: 10.1016/j.visres.2024.108507.


Neo-epitope detection identifies extracellular matrix turnover in systemic inflammation and sepsis: an exploratory study.

Fan Y, Moser J, van Meurs M, Kiers D, Sand J, Leeming D Crit Care. 2024; 28(1):120.

PMID: 38609959 PMC: 11010428. DOI: 10.1186/s13054-024-04904-4.


Immune Analysis Using Vitreous Optical Coherence Tomography Imaging in Rats with Steroid-Induced Glaucoma.

Rodrigo M, Subias M, Montolio A, Martinez-Rincon T, Aragon-Navas A, Bravo-Osuna I Biomedicines. 2024; 12(3).

PMID: 38540246 PMC: 10967960. DOI: 10.3390/biomedicines12030633.


Electrospun Nanofibers Encapsulated with Natural Products: A Novel Strategy to Counteract Skin Aging.

Serra D, Garroni G, Cruciani S, Coradduzza D, Pashchenko A, Amler E Int J Mol Sci. 2024; 25(3).

PMID: 38339184 PMC: 10856659. DOI: 10.3390/ijms25031908.


References
1.
Karsdal M, Nielsen M, Sand J, Henriksen K, Genovese F, Bay-Jensen A . Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure. Assay Drug Dev Technol. 2012; 11(2):70-92. PMC: 3593693. DOI: 10.1089/adt.2012.474. View

2.
Bosman F, Stamenkovic I . Functional structure and composition of the extracellular matrix. J Pathol. 2003; 200(4):423-8. DOI: 10.1002/path.1437. View

3.
Langley R, Fidler I . The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer. 2011; 128(11):2527-35. PMC: 3075088. DOI: 10.1002/ijc.26031. View

4.
Martinez J, Olmos J, Hernandez J, Pinedo G, Llorca J, Obregon E . Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study. Clin Chim Acta. 2009; 409(1-2):70-4. DOI: 10.1016/j.cca.2009.08.020. View

5.
Vasikaran S, Eastell R, Bruyere O, Foldes A, Garnero P, Griesmacher A . Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2010; 22(2):391-420. DOI: 10.1007/s00198-010-1501-1. View